6.102
Precedente Chiudi:
$5.90
Aprire:
$5.93
Volume 24 ore:
53,615
Relative Volume:
0.70
Capitalizzazione di mercato:
$202.86M
Reddito:
$8.98M
Utile/perdita netta:
$-31.39M
Rapporto P/E:
-4.5537
EPS:
-1.34
Flusso di cassa netto:
$-24.83M
1 W Prestazione:
-1.58%
1M Prestazione:
+15.79%
6M Prestazione:
-18.75%
1 anno Prestazione:
-29.38%
Profound Medical Corp Stock (PROF) Company Profile
Nome
Profound Medical Corp
Settore
Industria
Telefono
647-476-1350
Indirizzo
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
Confronta PROF con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
PROF
Profound Medical Corp
|
6.102 | 202.86M | 8.98M | -31.39M | -24.83M | -1.34 |
![]()
ABT
Abbott Laboratories
|
136.26 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
104.78 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
396.74 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
88.75 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
77.18 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Profound Medical Corp Stock (PROF) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-07-23 | Iniziato | Lake Street | Buy |
2024-07-16 | Aggiornamento | Stifel | Hold → Buy |
2023-11-28 | Iniziato | Stifel | Hold |
2023-08-04 | Downgrade | Raymond James | Strong Buy → Outperform |
2023-03-21 | Downgrade | Jefferies | Buy → Hold |
2020-09-15 | Iniziato | Jefferies | Buy |
Mostra tutto
Profound Medical Corp Borsa (PROF) Ultime notizie
(PRN) Stock Trading Blueprint (PRN:CA) - news.stocktradersdaily.com
Profound Medical: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (PRN) - The Globe and Mail
How To Trade (PRN) (PRN:CA) - news.stocktradersdaily.com
Global Uterine Fibroids Treatment Devices Market is - GlobeNewswire
(PRN) Advanced Equity Analysis (PRN:CA) - news.stocktradersdaily.com
Following a 26% decline over last year, recent gains may please Profound Medical Corp. (TSE:PRN) institutional owners - simplywall.st
Profound Medical (NASDAQ:PROF) Shares Up 17.4% – What’s Next? - Defense World
Regulatory Affairs in Life Sciences - Fasken
Profound Medical (PROF) Advances BPH Treatment with New Module | - GuruFocus
Profound Medical announces first commercial BPH treatment using TULSA-AI - TipRanks
Profound Medical (PROF) Advances BPH Treatment with New Module | PROF Stock News - GuruFocus
Profound Medical Brief: Announcing First Commercial BPH Patient Treatment Using TULSA-PRO with TULSA-AI Volume Reduction - MarketScreener
Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction - Yahoo Finance
(PRN) Trading Performance and Risk Management (PRN:CA) - news.stocktradersdaily.com
Learn to Evaluate (PRN) using the Charts (PRN:CA) - news.stocktradersdaily.com
Profound Medical (PROF) Partners with Leonard Wheeler to Boost T - GuruFocus
Profound Medical (PROF) Partners with Leonard Wheeler to Boost TULSA-PRO Awareness | PROF Stock News - GuruFocus
Profound Medical Partners with NFL Legend Leonard Wheeler to Promote TULSA-PRO - TipRanks
Profound Medical enters agreement with former NFL player Leonard Wheeler - TipRanks
Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassado - GuruFocus
Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO® | PROF Stock News - GuruFocus
Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO® - The Manila Times
(PRN) Equity Market Report (PRN:CA) - news.stocktradersdaily.com
(PRN) Trading Report (PRN:CA) - news.stocktradersdaily.com
Long Term Trading Analysis for (PRN) (PRN:CA) - news.stocktradersdaily.com
Where are the Opportunities in (PRN) (PRN:CA) - news.stocktradersdaily.com
1 Magnificent Healthcare Stock Down 80% to Buy and Hold Forever - MSN
(PRN) Stock Market Analysis (PRN:CA) - news.stocktradersdaily.com
Profound Medical CEO Arun Menawat buys $100,150 in shares By Investing.com - Investing.com Canada
Insider Buying: Arun Menawat Acquires Shares of Profound Medical Corp (PROF) - GuruFocus
Profound Medical CEO Arun Menawat buys $100,150 in shares - Investing.com Australia
Profound Medical targets 70%-75% growth in 2025 with new TULSA AI module launch - MSN
Arun Menawat Bought 2.1% More Shares In Profound Medical - Yahoo Finance
(PRN) Financial Trading Report (PRN:CA) - news.stocktradersdaily.com
Profound Medical announces shareholder vote results - Investing.com Australia
Objective long/short (PRN) Report (PRN:CA) - news.stocktradersdaily.com
Profound Medical Annual General and Special Meeting of Shareholders Voting Results - The Manila Times
Profound Medical announces shareholder vote results By Investing.com - Investing.com South Africa
Profound Medical Corp. Announces Successful Shareholder Meeting Outcomes - TipRanks
Profound Medical Annual General and Special Meeting of Shareholders Voting Results | PROF Stock News - GuruFocus
Why Coinbase Global Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket - Benzinga
(PRN) Pivots Trading Plans and Risk Controls (PRN:CA) - news.stocktradersdaily.com
Profound Medical First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Profound Medical Corp. (NASDAQ:PROF) Q1 2025 Earnings Call Transcript - Insider Monkey
Profound Medical stock rating downgraded at Raymond James By Investing.com - Investing.com Nigeria
Profound Medical stock rating downgraded at Raymond James - Investing.com
Profound Medical (PROF) Downgraded by Raymond James Amid Economic Concerns | PROF Stock News - GuruFocus
Profound Medical Q1 2025 revenue jumps 82% - Medical Buyer
Profound Medical Corp (PROF) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ... By GuruFocus - Investing.com Canada
Profound Medical Corp (PROF) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ... - Yahoo Finance
Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Profound Medical Corp Azioni (PROF) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Profound Medical Corp Azioni (PROF) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Menawat Arun Swarup | CEO |
May 15 '25 |
Buy |
4.33 |
10,003 |
43,263 |
575,062 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):